Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine M Lusk

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
JTO Clinical and Research Reports|July 26, 2022
Lung Cancer Screening Criteria and Cardiopulmonary ComorbiditiesChan Yeu Pu, Christine M Lusk, Christine Neslund-Dudas, et al.
JAMA Oncology|January 13, 2022
Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in EligibilityChan Yeu Pu, Christine M Lusk, Christine Neslund-Dudas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 14, 2023
Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black PopulationsMatthew R Trendowski, Christine M Lusk, Angela S Wenzlaff, et al.
Journal of Occupational and Environmental Medicine|March 29, 2003
Bladder cancer screening program for a petrochemical cohort with potential exposure to beta-napthylamineSarah A Felknor, George L Delclos, Seth P Lerner, et al.
JCO Precision Oncology|January 24, 2025
Association of Germline Pathogenic Variants in <i>MUTYH</i> and Other DNA Damage Response Genes With Lung Cancer Risk Among Non-Hispanic Whites and African AmericansMatthew R Trendowski, Christine M Lusk, Angela S Wenzlaff, et al.
Human Genetics|June 4, 2014
Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities studyChristine M Lusk, Greg Dyson, Andrew G Clark, et al.
Carcinogenesis|January 1, 2016
Whole-exome sequencing reveals genetic variability among lung cancer cases subphenotyped for emphysemaChristine M Lusk, Angela S Wenzlaff, Greg Dyson, et al.
International Journal of Cancer|November 12, 2019
COPD-dependent effects of genetic variation in key inflammation pathway genes on lung cancer riskDonovan Watza, Christine M Lusk, Gregory Dyson, et al.
Carcinogenesis|September 12, 2018
Prognostic modeling of the immune-centric transcriptome reveals interleukin signaling candidates contributing to differential patient outcomesDonovan Watza, Christine M Lusk, Gregory Dyson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer PatientsChristine M Lusk, Donovan Watza, Greg Dyson, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
JTO Clinical and Research Reports|July 26, 2022
Lung Cancer Screening Criteria and Cardiopulmonary ComorbiditiesChan Yeu Pu, Christine M Lusk, Christine Neslund-Dudas, et al.
JAMA Oncology|January 13, 2022
Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in EligibilityChan Yeu Pu, Christine M Lusk, Christine Neslund-Dudas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 14, 2023
Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black PopulationsMatthew R Trendowski, Christine M Lusk, Angela S Wenzlaff, et al.
Journal of Occupational and Environmental Medicine|March 29, 2003
Bladder cancer screening program for a petrochemical cohort with potential exposure to beta-napthylamineSarah A Felknor, George L Delclos, Seth P Lerner, et al.
JCO Precision Oncology|January 24, 2025
Association of Germline Pathogenic Variants in <i>MUTYH</i> and Other DNA Damage Response Genes With Lung Cancer Risk Among Non-Hispanic Whites and African AmericansMatthew R Trendowski, Christine M Lusk, Angela S Wenzlaff, et al.
Human Genetics|June 4, 2014
Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities studyChristine M Lusk, Greg Dyson, Andrew G Clark, et al.
Carcinogenesis|January 1, 2016
Whole-exome sequencing reveals genetic variability among lung cancer cases subphenotyped for emphysemaChristine M Lusk, Angela S Wenzlaff, Greg Dyson, et al.
International Journal of Cancer|November 12, 2019
COPD-dependent effects of genetic variation in key inflammation pathway genes on lung cancer riskDonovan Watza, Christine M Lusk, Gregory Dyson, et al.
Carcinogenesis|September 12, 2018
Prognostic modeling of the immune-centric transcriptome reveals interleukin signaling candidates contributing to differential patient outcomesDonovan Watza, Christine M Lusk, Gregory Dyson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer PatientsChristine M Lusk, Donovan Watza, Greg Dyson, et al.
Pageof 2